Table 1.
Clinic-pathological characteristics of inflammatory breast cancer (IBC) and non-IBC patients.
| Characteristic | IBC (n = 17) | Non-IBC (n = 18) | p Value |
|---|---|---|---|
| Age (years) | |||
| Range | 33–82 | 32–73 | 0.806 a |
| Mean ± SEM | 54.4 ± 3.2 | 53.3 ± 2.7 | |
| Tumor size (cm), n (%) | |||
| ≤4 | 6 (35) | 11(61) | 0.11 b |
| >4 | 9 (53) | 5 (28) | |
| NA | 2 (12) | 2 (11) | |
| Lymph node status, n (%) | |||
| <4 | 5 (29) | 12 (67) | 0.02 * b |
| ≥4 | 10 (59) | 4 (22) | |
| NA | 2 (12) | 2 (11) | |
| Tumor grade, n (%) | |||
| Grade I | 0 (0) | 1 (5) | 0.14 b |
| Grade II | 11 (65) | 12 (67) | |
| Grade III | 4 (23) | 2 (11) | |
| NA | 2 (12) | 3 (17) | |
| Lymphovascular invasion, n (%) | |||
| Negative | 4 (23) | 11 (61) | 0.005 * b |
| Positive | 11 (65) | 3 (17) | |
| NA | 2 (12) | 4 (22) | |
| ER, n (%) | |||
| Negative | 8 (47) | 9 (50) | 0.85 b |
| Positive NA |
7 (41) 2 (12) |
9 (50) 0 (0) |
|
| PR, n (%) | |||
| Negative | 10 (59) | 10 (56) | 0.83 b |
| Positive NA |
7 (41) 0 (0) |
6 (33) 2 (11) |
|
| Her2, n (%) | |||
| Negative | 10 (59) | 12 (66) | 0.28 b |
| Positive NA |
6 (35) 1 (6) |
3 (17) 3 (17) |
Data are expressed as mean ± SEM, NA Data not available; * Significant p value calculated by a Student’s t-test or b Pearson Chi-Square. ER, estrogen receptor; PR, progesterone receptor; Her2, human epidermal growth factor receptor 2.